Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats

S. M. Cohen, S. Fukushima, H. Tsuda, G. Murasaki, N. Ito

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effect of azathiopurine and OK-432 on bladder carcinogenesis in rats was evaluated using the carcinogens, N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) and N-[4-(5-nitro-2-furyl-2-thiazolyl]formamide (FANFT). Azathiopurine did not affect FANFT bladder carcinogenesis in any treatment. By contrast, when azathiopurine was fed simultaneously with BBN there was a significant increase in the incidence of bladder tumors, although it had no effect if administered before or after BBN. Short-term administration (8 weeks) of OK-432 subcutaneously before, during, or after BBN did not affect bladder carcinogenesis, but if OK-432 was begun after BBN and continued until the end of the experiment, the incidence of BBN-induced bladder tumor was significantly reduced. No bladder lesions were observed in control rats or in rats receiving only azathiopurine or OK-432.

Original languageEnglish (US)
Pages (from-to)773-779
Number of pages7
JournalGann, The Japanese Journal of Cancer Research
Volume69
Issue number6
StatePublished - Dec 1 1978

Fingerprint

Picibanil
FANFT
Carcinogenesis
Urinary Bladder
Urinary Bladder Neoplasms
Butylhydroxybutylnitrosamine
Incidence
Carcinogens
azathiopurine

ASJC Scopus subject areas

  • Cancer Research

Cite this

Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats. / Cohen, S. M.; Fukushima, S.; Tsuda, H.; Murasaki, G.; Ito, N.

In: Gann, The Japanese Journal of Cancer Research, Vol. 69, No. 6, 01.12.1978, p. 773-779.

Research output: Contribution to journalArticle

Cohen, SM, Fukushima, S, Tsuda, H, Murasaki, G & Ito, N 1978, 'Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats', Gann, The Japanese Journal of Cancer Research, vol. 69, no. 6, pp. 773-779.
Cohen, S. M. ; Fukushima, S. ; Tsuda, H. ; Murasaki, G. ; Ito, N. / Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats. In: Gann, The Japanese Journal of Cancer Research. 1978 ; Vol. 69, No. 6. pp. 773-779.
@article{4586bfbcba4441f8b794f17a01a2067f,
title = "Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats",
abstract = "The effect of azathiopurine and OK-432 on bladder carcinogenesis in rats was evaluated using the carcinogens, N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) and N-[4-(5-nitro-2-furyl-2-thiazolyl]formamide (FANFT). Azathiopurine did not affect FANFT bladder carcinogenesis in any treatment. By contrast, when azathiopurine was fed simultaneously with BBN there was a significant increase in the incidence of bladder tumors, although it had no effect if administered before or after BBN. Short-term administration (8 weeks) of OK-432 subcutaneously before, during, or after BBN did not affect bladder carcinogenesis, but if OK-432 was begun after BBN and continued until the end of the experiment, the incidence of BBN-induced bladder tumor was significantly reduced. No bladder lesions were observed in control rats or in rats receiving only azathiopurine or OK-432.",
author = "Cohen, {S. M.} and S. Fukushima and H. Tsuda and G. Murasaki and N. Ito",
year = "1978",
month = "12",
day = "1",
language = "English (US)",
volume = "69",
pages = "773--779",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats

AU - Cohen, S. M.

AU - Fukushima, S.

AU - Tsuda, H.

AU - Murasaki, G.

AU - Ito, N.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - The effect of azathiopurine and OK-432 on bladder carcinogenesis in rats was evaluated using the carcinogens, N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) and N-[4-(5-nitro-2-furyl-2-thiazolyl]formamide (FANFT). Azathiopurine did not affect FANFT bladder carcinogenesis in any treatment. By contrast, when azathiopurine was fed simultaneously with BBN there was a significant increase in the incidence of bladder tumors, although it had no effect if administered before or after BBN. Short-term administration (8 weeks) of OK-432 subcutaneously before, during, or after BBN did not affect bladder carcinogenesis, but if OK-432 was begun after BBN and continued until the end of the experiment, the incidence of BBN-induced bladder tumor was significantly reduced. No bladder lesions were observed in control rats or in rats receiving only azathiopurine or OK-432.

AB - The effect of azathiopurine and OK-432 on bladder carcinogenesis in rats was evaluated using the carcinogens, N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) and N-[4-(5-nitro-2-furyl-2-thiazolyl]formamide (FANFT). Azathiopurine did not affect FANFT bladder carcinogenesis in any treatment. By contrast, when azathiopurine was fed simultaneously with BBN there was a significant increase in the incidence of bladder tumors, although it had no effect if administered before or after BBN. Short-term administration (8 weeks) of OK-432 subcutaneously before, during, or after BBN did not affect bladder carcinogenesis, but if OK-432 was begun after BBN and continued until the end of the experiment, the incidence of BBN-induced bladder tumor was significantly reduced. No bladder lesions were observed in control rats or in rats receiving only azathiopurine or OK-432.

UR - http://www.scopus.com/inward/record.url?scp=0018242123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018242123&partnerID=8YFLogxK

M3 - Article

C2 - 750272

AN - SCOPUS:0018242123

VL - 69

SP - 773

EP - 779

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 6

ER -